⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

February 22, 2024Molecular Nutrition & Food Research

Astragaloside IV Mitigated Diabetic Nephropathy by Restructuring Intestinal Microflora and Ferroptosis

Xin Lyu Tingting Zhang Zhen Ye Ce Chen

View Full Paper

Ask AI

Bookmark

Share

Abstract

To investigate the underlying mechanism of Astragaloside IV (AS-IV) in ameliorating diabetic nephropathy (DN) by regulating intestinal microbiota ecology and intestinal mucosal barrier.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Lyu et al. (2024) studied this question.

synapsesocial.com/papers/68e77f57b6db6435876f34cd https://doi.org/10.1002/mnfr.202300734

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Astragaloside IV Ameliorates Diabetic Kidney Disease via Inhibiting MAPK Pathway and Alleviating Metabolic DysregulationOriginal Research · 2026
2Astragaloside <scp>IV</scp> Exhibited Antidiabetic Effects by Improving Glucose Metabolism, Repairing Damaged Gut Barrier and Regulating Intestinal MicrobiotaOriginal Research · 2026
3Astragaloside IV reduces diabetic kidney injury by inhibiting the PKC/NOX4/MAPK pathway2025 · 5 citations
4The beneficial effects of astragaloside IV on ameliorating diabetic kidney diseasereview · 2023 · 46 citations
5Study on the Potential Mechanism of Astragaloside IV on Renoprotection in Db/Db Mice via Network Pharmacology and Experimental ValidationOriginal Research · 2026